Pediatric mendelian genomics research center
Active Cooperative Agreement Awarded Last action
- Award ID
- U01HG011745
- Recipient
-
University Of California Irvine UEI MJC5FCYQTPE6
- Awarding agency
-
National Human Genome Research Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $51,568,993
Award facts
- Assistance listing
- 93.172 Human Genome Research
- Completion date 92% complete
- Originally
- Funding
-
- $46,445,262.00 Federal
- $5,123,731.00 Non-federal
- Place of performance
- Irvine, CA 92617, USA
Award details come from USAspending.gov.
Description
- Abstract
- Mendelian conditions, particularly those presenting during childhood, are a major disease burden causing suffering and taxing the healthcare system. Clinical approaches including exome sequencing have led to a rapid increase in the number of conditions with known genetic causes and new treatment options for many rare diseases, but are restricted to finding small coding and splice junction variants, missing most non-coding variants as well as structural and copy number variants. This challenges interpretation due to the vast number of variants that must be analyzed for possibly causing a disease. To accelerate the pace of mendelian disease gene discovery and clinical implementation, we propose a pediatric mendelian genomics research center (mgrc), leveraging the broad pediatric clinical and research expertise of children's national hospital and research institute in a partnership with invitae's expertise in providing comprehensive and affordable genetic testing. Our center will unite world class experts combining basic and translational research with innovative approaches to phenotyping, variant identification and functional investigation of both coding and non-coding sequence changes with the goals of discovering novel mendelian gene variations and identifying variants not detected on current sequencing pipelines, disambiguating uncertain variants into disease-causing versus benign categorizations, and sharing information by working collaboratively with the mgrc community. To answer these challenges, this proposal will address the following specific aims: aim 1: identify novel causes of mendelian conditions - discover: our center will enroll patients with likely mendelian diseases and previously non-diagnostic tests (2,600 samples per year) then systematically RE- analyze whole genomes augmented with long read sequencing, optical mapping, and RNA-SEQ. Aim 2: reclassify uncertain variants and investigate the mechanisms of undiagnosed mendelian conditions - disambiguate: uncertain variants and candidate genes will be further investigated using whole transcriptome analysis, RNA-SEQ, CRE-SEQ, and functional modeling. Aim 3: communicate research results to enable translational research on new and rare mendelian conditions - disseminate: our center is committed to data sharing and dissemination and will ensure that data is shared with the entire mgrc community through the data coordinating center. Through our industry partnership, clinically valid pipelines will be rapidly scaled for clinical implementation globally. Our overall approach provides an efficient and direct path to diagnosis for patients affected with undiagnosed mendelian conditions, promotes gene discovery and reclassification of variants of uncertain significance through a combination of innovative approaches, and will allow individuals, families and healthcare providers to improve the management of disease.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,863,473 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $2,074,563 | |
| Amendment | $2,074,563 | |
| Amendment | $2,074,563 | |
| Amendment | $2,074,563 | |
| Amendment | $2,074,563 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $171,164 | |
| Amendment | $171,164 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,925,591 | |
| Amendment | $1,925,591 | |
| Amendment | $1,925,591 | |
| Amendment | $1,925,591 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | -$2,559,010 | |
| Amendment | $3,913,701 | |
| Amendment | -$1,354,691 | |
| Amendment | -$1,354,691 | |
| Amendment | $3,913,701 | |
| Amendment | -$1,354,691 | |
| Amendment | -$1,354,691 | |
| Amendment | -$2,559,010 | |
| Amendment | -$2,559,010 | |
| Amendment | $3,913,701 | |
| Amendment | -$2,559,010 | |
| Amendment | $3,913,701 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $2,159,760 | |
| Amendment | $2,159,760 | |
| Amendment | $2,159,760 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 |
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Ambry Genetics Corporation | $253,800 | |
| Ambry Genetics Corporation | $460,000 | |
| Ambry Genetics Corporation | $218,750 | |
| Ambry Genetics Corporation | $218,750 | |
| Ambry Genetics Corporation | $35,652 | |
| Children's Research Institute | $64,526 | |
| Children's Research Institute | $187,222 | |
| Ambry Genetics Corporation | $2,382,885 | |
| Invitae Corporation | $541,390 | |
| Children's Research Institute | $215,773 | |
| Invitae Corporation | $990,284 | |
| Children's Research Institute | $430,300 |
Show all 12
Quick answers
Who received award U01HG011745?
U01HG011745 was awarded to University Of California Irvine by National Human Genome Research Institute (National Institutes of Health) on June 1, 2021.
How much is award U01HG011745 worth?
$51,568,993 has been obligated on U01HG011745: $46,445,262 in federal funding and $5,123,731 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award